{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:52:11Z","timestamp":1792792331197,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chongqing Overseas Chinese Returned Entrepreneurship and Innovation Support Program of P. R. China","award":["cx2021095"],"award-info":[{"award-number":["cx2021095"]}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2022NSCQ-BHX0686"],"award-info":[{"award-number":["CSTB2022NSCQ-BHX0686"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX0141"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0141"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06294-9","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T10:19:22Z","timestamp":1740997162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A novel lncRNA FLJ promotes castration resistance in prostate cancer through AR mediated autophagy"],"prefix":"10.1186","volume":"23","author":[{"given":"Yingying","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojie","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohou","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunli","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1005-5964","authenticated-orcid":false,"given":"Liping","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"issue":"3","key":"6294_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"6294_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"6294_CR3","first-page":"1607","volume":"12","author":"D Basak","year":"2022","unstructured":"Basak D, Gregori L, Johora F, Deb S. Preclinical and clinical research models of prostate cancer: a brief overview. Life (Basel). 2022;12(10):1607.","journal-title":"Life (Basel)"},{"issue":"3","key":"6294_CR4","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.3390\/ijms23031216","volume":"23","author":"M Corti","year":"2022","unstructured":"Corti M, Lorenzetti S, Ubaldi A, Zilli R, Marcoccia D. Endocrine disruptors and prostate cancer. Int J Mol Sci. 2022;23(3):1216.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"6294_CR5","doi-asserted-by":"publisher","first-page":"602","DOI":"10.7150\/ijbs.8844","volume":"10","author":"EA Mostaghel","year":"2014","unstructured":"Mostaghel EA. Beyond T and DHT\u2014novel steroid derivatives capable of wild type androgen receptor activation. Int J Biol Sci. 2014;10(6):602\u201313.","journal-title":"Int J Biol Sci"},{"issue":"5","key":"6294_CR6","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3390\/cancers15051621","volume":"15","author":"S Gogola","year":"2023","unstructured":"Gogola S, Rejzer M, Bahmad HF, Alloush F, Omarzai Y, Poppiti R. Anti-cancer stem-cell-targeted therapies in prostate cancer. Cancers (Basel). 2023;15(5):1621.","journal-title":"Cancers (Basel)"},{"key":"6294_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.873876","volume":"12","author":"P Kong","year":"2022","unstructured":"Kong P, Zhang L, Zhang Z, Feng K, Sang Y, Duan X, Liu C, Sun T, Tao Z, Liu W. Emerging proteins in CRPC: functional roles and clinical implications. Front Oncol. 2022;12: 873876.","journal-title":"Front Oncol"},{"issue":"6","key":"6294_CR8","doi-asserted-by":"publisher","first-page":"613","DOI":"10.2174\/1389450118666170417144250","volume":"19","author":"X Chen","year":"2018","unstructured":"Chen X, Lu J, Xia L, Li G. Drug resistance of enzalutamide in CRPC. Curr Drug Targets. 2018;19(6):613\u201320.","journal-title":"Curr Drug Targets"},{"issue":"3","key":"6294_CR9","first-page":"365","volume":"4","author":"T Chandrasekar","year":"2015","unstructured":"Chandrasekar T, Yang JC, Gao AC, Evans CP. Mechanisms of resistance in castration-resistant prostate cancer (CRPC). Transl Androl Urol. 2015;4(3):365\u201380.","journal-title":"Transl Androl Urol"},{"key":"6294_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.semcancer.2020.12.012","volume":"75","author":"EM McCabe","year":"2021","unstructured":"McCabe EM, Rasmussen TP. lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions. Semin Cancer Biol. 2021;75:38\u201348.","journal-title":"Semin Cancer Biol"},{"issue":"11","key":"6294_CR11","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.3390\/cells10113198","volume":"10","author":"M Taheri","year":"2021","unstructured":"Taheri M, Khoshbakht T, Jamali E, Kallenbach J, Ghafouri-Fard S, Baniahmad A. Interaction between non-coding RNAs and androgen receptor with an especial focus on prostate cancer. Cells. 2021;10(11):3198.","journal-title":"Cells"},{"issue":"6","key":"6294_CR12","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/s41588-018-0120-1","volume":"50","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Pitchiaya S, Cie\u015blik M, Niknafs YS, Tien JC, Hosono Y, Iyer MK, Yazdani S, Subramaniam S, Shukla SK, et al. Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression. Nat Genet. 2018;50(6):814\u201324.","journal-title":"Nat Genet"},{"issue":"6","key":"6294_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nrendo.2014.35","volume":"10","author":"KH Kim","year":"2014","unstructured":"Kim KH, Lee MS. Autophagy\u2013a key player in cellular and body metabolism. Nat Rev Endocrinol. 2014;10(6):322\u201337.","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"6294_CR14","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1158\/2159-8290.CD-19-0292","volume":"9","author":"RK Amaravadi","year":"2019","unstructured":"Amaravadi RK, Kimmelman AC, Debnath J. Targeting autophagy in cancer: recent advances and future directions. Cancer Discov. 2019;9(9):1167\u201381.","journal-title":"Cancer Discov"},{"key":"6294_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102043","volume":"88","author":"L Mele","year":"2020","unstructured":"Mele L, Del Vecchio V, Liccardo D, Prisco C, Schwerdtfeger M, Robinson N, Desiderio V, Tirino V, Papaccio G, La Noce M. The role of autophagy in resistance to targeted therapies. Cancer Treat Rev. 2020;88: 102043.","journal-title":"Cancer Treat Rev"},{"issue":"9","key":"6294_CR16","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrm2239","volume":"8","author":"MC Maiuri","year":"2007","unstructured":"Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol. 2007;8(9):741\u201352.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"6294_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13046-019-1516-1","volume":"39","author":"M Ding","year":"2020","unstructured":"Ding M, Jiang CY, Zhang Y, Zhao J, Han BM, Xia SJ. SIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer. J Exp Clin Cancer Res. 2020;39(1):28.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"6294_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ctrv.2013.07.008","volume":"40","author":"S Wen","year":"2014","unstructured":"Wen S, Niu Y, Lee SO, Chang C. Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death. Cancer Treat Rev. 2014;40(1):31\u201340.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"6294_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.celrep.2015.08.069","volume":"13","author":"A Zhang","year":"2015","unstructured":"Zhang A, Zhao JC, Kim J, Fong KW, Yang YA, Chakravarti D, Mo YY, Yu J. LncRNA HOTAIR enhances the androgen-receptor-mediated transcriptional program and drives castration-resistant prostate cancer. Cell Rep. 2015;13(1):209\u201321.","journal-title":"Cell Rep"},{"issue":"4","key":"6294_CR20","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.bulcan.2020.11.022","volume":"108","author":"S Huang","year":"2021","unstructured":"Huang S, Liao Q, Li W, Deng G, Jia M, Fang Q, Ji H, Meng M. The lncRNA PTTG3P promotes the progression of CRPC via upregulating PTTG1. Bull Cancer. 2021;108(4):359\u201368.","journal-title":"Bull Cancer"},{"issue":"8","key":"6294_CR21","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1016\/j.ymthe.2017.04.016","volume":"25","author":"P Gu","year":"2017","unstructured":"Gu P, Chen X, Xie R, Han J, Xie W, Wang B, Dong W, Chen C, Yang M, Jiang J, et al. lncRNA HOXD-AS1 regulates proliferation and chemo-resistance of castration-resistant prostate cancer via recruiting WDR5. Mol Ther. 2017;25(8):1959\u201373.","journal-title":"Mol Ther"},{"issue":"13","key":"6294_CR22","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1007\/s00018-016-2174-5","volume":"73","author":"SU Schmitz","year":"2016","unstructured":"Schmitz SU, Grote P, Herrmann BG. Mechanisms of long noncoding RNA function in development and disease. Cell Mol Life Sci. 2016;73(13):2491\u2013509.","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"6294_CR23","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1158\/1541-7786.MCR-14-0257","volume":"12","author":"R Malik","year":"2014","unstructured":"Malik R, Patel L, Prensner JR, Shi Y, Iyer MK, Subramaniyan S, Carley A, Niknafs YS, Sahu A, Han S, et al. The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer. Mol Cancer Res. 2014;12(8):1081\u20137.","journal-title":"Mol Cancer Res"},{"issue":"8","key":"6294_CR24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.neo.2016.07.001","volume":"18","author":"S Shukla","year":"2016","unstructured":"Shukla S, Zhang X, Niknafs YS, Xiao L, Mehra R, Cie\u015blik M, Ross A, Schaeffer E, Malik B, Guo S, et al. Identification and validation of PCAT14 as prognostic biomarker in prostate cancer. Neoplasia. 2016;18(8):489\u201399.","journal-title":"Neoplasia"},{"issue":"2","key":"6294_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96\u2013118.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"6294_CR26","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3390\/cells12050810","volume":"12","author":"A Kumar","year":"2023","unstructured":"Kumar A, Girisa S, Alqahtani MS, Abbas M, Hegde M, Sethi G, Kunnumakkara AB. Targeting autophagy using long non-coding RNAs (LncRNAs): new landscapes in the arena of cancer therapeutics. Cells. 2023;12(5):810.","journal-title":"Cells"},{"issue":"6","key":"6294_CR27","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20187080","volume":"51","author":"C Chen","year":"2018","unstructured":"Chen C, Wang K, Wang Q, Wang X. LncRNA HULC mediates radioresistance via autophagy in prostate cancer cells. Braz J Med Biol Res. 2018;51(6): e7080.","journal-title":"Braz J Med Biol Res"},{"key":"6294_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.552907","volume":"10","author":"J Chen","year":"2020","unstructured":"Chen J, Wang F, Xu H, Xu L, Chen D, Wang J, Huang S, Wen Y, Fang L. Long non-coding RNA SNHG1 regulates the Wnt\/\u03b2-catenin and PI3K\/AKT\/mTOR signaling pathways via EZH2 to affect the proliferation, apoptosis, and autophagy of prostate cancer cell. Front Oncol. 2020;10: 552907.","journal-title":"Front Oncol"},{"issue":"6","key":"6294_CR29","doi-asserted-by":"publisher","first-page":"703","DOI":"10.4161\/rna.20481","volume":"9","author":"T Gutschner","year":"2012","unstructured":"Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9(6):703\u201319.","journal-title":"RNA Biol"},{"issue":"3","key":"6294_CR30","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1158\/0008-5472.CAN-12-2850","volume":"73","author":"T Gutschner","year":"2013","unstructured":"Gutschner T, H\u00e4mmerle M, Eissmann M, Hsu J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013;73(3):1180\u20139.","journal-title":"Cancer Res"},{"issue":"12","key":"6294_CR31","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1038\/mt.2015.170","volume":"23","author":"X Zhao","year":"2015","unstructured":"Zhao X, Wang P, Liu J, Zheng J, Liu Y, Chen J, Xue Y. Gas5 exerts tumor-suppressive functions in human glioma cells by targeting miR-222. Mol Ther. 2015;23(12):1899\u2013911.","journal-title":"Mol Ther"},{"issue":"1","key":"6294_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrneurol.2017.148","volume":"14","author":"C Rinaldi","year":"2018","unstructured":"Rinaldi C, Wood MJA. Antisense oligonucleotides: the next frontier for treatment of neurological disorders. Nat Rev Neurol. 2018;14(1):9\u201321.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"6294_CR33","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.celrep.2019.12.011","volume":"30","author":"K Schmidt","year":"2020","unstructured":"Schmidt K, Weidmann CA, Hilimire TA, Yee E, Hatfield BM, Schneekloth JS Jr, Weeks KM, Novina CD. Targeting the oncogenic long non-coding RNA SLNCR1 by blocking its sequence-specific binding to the androgen receptor. Cell Rep. 2020;30(2):541-554.e545.","journal-title":"Cell Rep"},{"issue":"2","key":"6294_CR34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S2213-8587(22)00353-9","volume":"11","author":"KK Ray","year":"2023","unstructured":"Ray KK, Troquay RPT, Visseren FLJ, Leiter LA, Scott Wright R, Vikarunnessa S, Talloczy Z, Zang X, Maheux P, Lesogor A, et al. Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial. Lancet Diabetes Endocrinol. 2023;11(2):109\u201319.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"6294_CR35","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41576-024-00693-2","volume":"25","author":"M Coan","year":"2024","unstructured":"Coan M, Haefliger S, Ounzain S, Johnson R. Targeting and engineering long non-coding RNAs for cancer therapy. Nat Rev Genet. 2024;25(8):578\u201395.","journal-title":"Nat Rev Genet"},{"issue":"7904","key":"6294_CR36","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41586-022-04537-z","volume":"604","author":"R Aguilar","year":"2022","unstructured":"Aguilar R, Spencer KB, Kesner B, Rizvi NF, Badmalia MD, Mrozowich T, Mortison JD, Rivera C, Smith GF, Burchard J, et al. Targeting Xist with compounds that disrupt RNA structure and X inactivation. Nature. 2022;604(7904):160\u20136.","journal-title":"Nature"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06294-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06294-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06294-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T10:19:27Z","timestamp":1740997167000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06294-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6294"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06294-9","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"assertion":[{"value":"5 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were approved by the Ethics Committee of Chongqing Medical University. Approval Number: 2022- K275.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"255"}}